, 2012 and Frieden, 2010) Together, the articles in this issue p

, 2012 and Frieden, 2010). Together, the articles in this issue provide a glimpse into strategies that communities used to prevent chronic diseases and associated health disparities in the United States. This issue complements an ever-increasing body of literature that describes Baf-A1 implementation and evaluations of CPPW strategies (Baronberg et al., 2013, Barragan et al., 2014, Beets et al., 2012, Brokenleg et al., 2014, Cavanaugh et al., 2013, Cavanaugh et al., 2014, Cole et al., 2013, Drach et al., 2012, Dunn et al., 2012, Huberty et al., 2013, Jaskiewicz et al., 2013, Jilcott Pitts et

al., 2012, Johns et al., 2012, Jordan et al., 2012, Kern et al., 2014, Lafleur et al., 2013, Larson et al., 2013, Leung et al., 2013, Mandel-Ricci et al., 2013, Pitts et al., 2013a, Pitts et al., 2013b, Robles et al., 2013, Wilson et al., 2012 and Young et al., 2013). In addition, the core principles for strengthening the science of community health described in the commentary by Goodman and colleagues (in this issue) highlight the demonstrated successes of the CPPW program.

Sustaining PSE changes will lay the groundwork for future successes and emerging approaches to achieve the collective goal of improving our nation’s health. Although CPPW was funded selleck kinase inhibitor for only 2 years, community-based prevention strategies were designed to have a continuous effect in lowering chronic disease rates. CPPW had the potential to reach more than 55 million people in 381 locations (Bunnell et al., 2012). The extensive reach of this large-scale effort to improve environmental influences on obesity and tobacco use should result ultimately in a substantial reduction in chronic diseases throughout the United States. The authors declare that there are no conflicts of interests. The Centers for Disease Control and Prevention (CDC) supported awardees in the Communities Putting Prevention to Work initiative through cooperative agreements; this

supplement is supported in Cell press part by CDC contract no. 200-2007-22643-0003 to ICF International, Inc. However, the findings and conclusions in this article are those of the authors and do not necessarily represent the views of the US Department of Health and Human Services or CDC. Users of this document should be aware that every funding source has different requirements governing the appropriate use of those funds. Under US law, no federal funds are permitted to be used for lobbying or to influence, directly or indirectly, specific pieces of pending or proposed legislation at the federal, state, or local levels. Organizations should consult appropriate legal counsel to ensure compliance with all rules, regulations, and restriction of any funding sources.

Leave a Reply

Your email address will not be published. Required fields are marked *

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>